Home
DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals, Inc. Market Share Analysis for November 2025

LEVULAN® KERASTICK® (aminolevulinic acid HCl) + BLU-U® Treatment for minimally to moderately thick actinic keratosis. Please see full Prescribing Information and Instructions for Use.

Health > Biotechnology and Pharmaceuticals

Domaindusapharma.com

Year Founded1991

Employees51 - 200

Annual Revenue$10M - $15M

DUSA Pharmaceuticals, Inc.

DUSA Pharmaceuticals, Inc. (including company regionals)

dusapharma.com

See more website traffic and engagement information

DUSA Pharmaceuticals, Inc. Revenue up to November 2025 is 10M - 15M

revenue generated by DUSA Pharmaceuticals, Inc. top domains

DUSA Pharmaceuticals, Inc. top domains revenue over 3 years

Revenue for DUSA Pharmaceuticals, Inc. top domains

dusapharma.com10M - 15M

See more with Sales Intelligence

Total visits to DUSA Pharmaceuticals, Inc.'s top domains

Understand DUSA Pharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in DUSA Pharmaceuticals, Inc.'s top domains

Analyze DUSA Pharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on DUSA Pharmaceuticals, Inc.'s top domains

See how DUSA Pharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

DUSA Pharmaceuticals, Inc. top competitors by domain

Top similar sites in November 2025, ranked by their affinity

canderm.comCompany NameCanderm Pharma incEmployees51 - 200HQCanada, MontrealAnnual revenue--Total visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by DUSA Pharmaceuticals, Inc.

These are the website technologies, by industry, used by DUSA Pharmaceuticals, Inc. top domains

Advertising (3)

Facebook Custom Audiences

Mobile (3)

Meta Viewport

Audio Video Media (2)

Flowplayer

Conversion & Analytics (2)

Google Analytics

More Technologies

5

See all

News & Signals from DUSA Pharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDusapharma files suit against Biofrontera AG.We refer to your query, a copy of which is attached herewith, vide your email dated today, July 12, 2018 seeking clarification on announcement submitted by us to the Exchange dated July 11, 2018, regarding SUNPHARMA: Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 11, 2018, titled "DUSA Pharmaceuticals, Inc. files lawsuit against Biofrontera Inc. for patent infringement, trade secret misappropriation, and tortious interference" Response: DUSA Pharmaceuticals, Inc (DUSA), our indirect wholly owned subsidiary company has requested the Court to assess the matter for infringement and to then decide the damages to be granted to DUSA.